Effect of latanoprost on cultured porcine corneal stromal cells

Current Eye Research

Volumn 30, Issue 10, 2005, Pages 871-879

  Wu, Kwou Yeung ^a   Wang, Hwei Zu ^a   Hong, Show Jen ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Corneal stromal cells; Fibronectin; Latanoprost; Type 1 collagen

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; FIBRONECTIN; FURA 2; LATANOPROST; LEUCINE; NITROBLUE TETRAZOLIUM; PROLINE; THYMIDINE; URIDINE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL CULTURE; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; CORNEA STROMA; DRUG EFFECT; DRUG INHIBITION; IMMUNOFLUORESCENCE TEST; INTRAOCULAR PRESSURE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; SPECTROFLUOROMETRY; WESTERN BLOTTING;

ANIMALS; BENZALKONIUM COMPOUNDS; CALCIUM; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN TYPE I; CORNEAL STROMA; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; INTRACELLULAR MEMBRANES; LEUCINE; PROLINE; PROSTAGLANDINS F, SYNTHETIC; STAINING AND LABELING; SWINE; TETRAZOLIUM SALTS; THIAZOLES; THYMIDINE; URIDINE;

EID: 31544464093     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680591006237     Document Type: Article

References (37)

1. Alm A, Widengard I, Kjellgren D, Soderstrom M, Fristrom B, Heijl A, Stjerschantz J. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol. 1995;79:12-16.
2. Suzuki M, Mishima HK, Masuda K, Araie M, Kitazawa Y, Azuma I. Efficacy and safety of latanoprost eye drops for glaucoma treatment: a 1-year study in Japan. Jpn J Ophthalmol. 2000;44:33-38.
3. Gabelt BT, Kaufman PL. Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 1989;49:389-402.
4. 2 analog, on aqueous humor dynamics in human eyes. Ophthalmology. 1993;100:1297-1304.
5. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci. 1997;38:2772-2780.
6. 2α-isopropyl ester. Arch Ophthalmol. 2001;119:1165-1170.
7. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 1997;38:2214-2223.
8. Kim JW, Lindsey JD, Wang N, Weinreb RN. Increased human scleral permeability with prostaglandin exposure. Invest Ophthalmol Vis Sci. 2001;42:1514-1521.
9. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp Eye Res. 1998;67:179-191.
10. 2α treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol. 1999;117:794-801.
11. Lee RE, Davison PF. The collagens of the developing bovine cornea. Exp Eye Res. 1984;39:639-652.
12. BenEzra D, Foidart JM. Collagens and non collagenous proteins in the human eye. I. Corneal stroma in vivo and keratocyte production in vitro. Curr Eye Res. 1981;1:101-110.
13. Andresen JL, Ledet T, Hager H, Josephsen K, Ehlers N. The influence of corneal stromal matrix proteins on the migration of human corneal fibroblasts. Exp Eye Res. 2000;71:33-43.
14. Ito K, Goto R, Matsunaga K, Sugimoto K, Uji Y. Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension. Jpn J Ophthalmol. 2004;48:276-280.
15. Ang A, Reddy MA, Shepstone L, Broadway DC. Long term effect of latanoprost on intraocular pressure in normal tension glaucoma. Br J Ophthalmol. 2004;88:630-634.
16. Wu KY, Hong SJ, Huang HT, Lin CP, Chen CW. Toxic effect of mitomycin-C on cultured porcine corneal keratocytes and endothelial cells. J Ocul Pharmacol Ther. 1999;15:401-411.
17. Wu KY, Hong SJ, Wang HZ, Lin CP, Lai YH. Induction of cellular toxicity in cultured porcine corneal keratocytes by endothelin-1. J Ocul Pharmacol Ther. 2001;17:449-460.
18. Wu KY, Hong SJ, Wang HZ, Lin CP, Lai YH. Endothelin-induced changes of secondary messenger in cultured porcine corneal endothelial cells. J Ocul Pharmacol Ther. 2001;17:351-361.
19. 2+ mobility in cultured H9c2 myocardiac ventricular cells. Cell Signal. 2002;14:811-817.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
21. Chandrasekher G, Ma X, Lallier TE, Bazan HE. Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor. Invest Ophthalmol Vis Sci. 2002;43:1422-1428.
22. Hirano S, Sagara T, Suzuki K, Seki K, Nishida T. Inhibitory effects of anti-glaucoma drugs on corneal epithelial migration in a rabbit organ culture system. J Glaucoma. 2004;13:196-199.
23. Long CJ, Roth MR, Tasheva ES, Funderburgh M, Smit R, Gary W., Conrad GW, Funderburgh JL. Fibroblast growth factor-2 promotes keratan sulfate proteoglycan expression by keratocytes. in Vitro. J Biol Chem. 2000;275:13918-13923.
24. Funderburgh JL, Mann MM, Funderburgh ML. Keratocyte Phenotype Mediates Proteoglycan Structure. J Biol Chem. 2003;278:45629-45637.
25. Mohan RR, Hutcheon AE, Choi R, Hong J, Lee J, Mohan RR, Ambrosio R Jr, Zieske JD, Wilson SE. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res. 2003;76:71-87.
26. Costagliola C, Del Prete A, Verolino M, Antinozzi P, Fusco R, Parmeggiani F, Mastropasqua L. Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients. Graefe's Arch Clin Exp Ophthalmol. 2002;240:379-386.
27. Hirano S, Sagara T, Suzuki K, Seki K, Nishida T. Inhibitory effects of anti-glaucoma drugs on corneal epithelial migration in a rabbit organ culture system. J Glaucoma. 2004;13:196-199.
28. Ding M, Burstein NL. Fibronectin in corneal wound healing. J Ocular. Pharmacol. 1988;4:75-91.
29. Fujikawa LS, Foster CS, Harrist TJ, Lanigan JM, Colvin RB. Fibronectin in healing rabbit corneal wounds. Lab Invest. 1981;45:120-129.
30. Keates RH, Bloom RT, Ren Q, Ringel DM, Erdey RA. Fibronectin on excimer laser and diamond knife incisions. J Cataract Refract Surg. 1989;15:404-408.
31. Vaheri A, Mosher DF. High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation. Biochim Biophys Acta. 1978;516:1-25.
32. Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490-496.
33. Eleftheriadis H, Cheong M, Sandeman S, Syam PP, Brittain P, Klintworth GK, Lloyd A, Liu C. Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery. Br J Ophthalmol. 2002;86:299-305.
34. Sjoquist B, Stjernschantz J. Ocular and systemic pharmacokinetics of latanoprost in humans. Surv Ophthalmol. 2002;47:6-12.
35. Sjoquist B, Basu S, Byding P, Bergh K, Stjernschantz J. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit. Drug Metab Dispos. 1998;26:745-754.
36. Telfair WB, Bekker C, Hoffman HJ, Yoder PR Jr, Nordquist RE, Eiferman RA, Zenzie HH. Histological comparison of corneal ablation with Er:YAG laser, Nd:YAG optical parametric oscillator, and excimer laser. J Refract Surg. 2000;16:40-50.
37. Krueger RR, Seiler T, Gruchman T, Mrochen M, Berlin MS. Stress wave amplitudes during laser surgery of the cornea. Ophthalmology. 2001;108:1070-10744.